{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:28:25Z","timestamp":1790702905914,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BTT"],"DOI":"10.2147\/btt.s31145","type":"journal-article","created":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T03:51:39Z","timestamp":1342065099000},"page":"201","source":"Crossref","is-referenced-by-count":10,"title":["Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study"],"prefix":"10.2147","author":[{"given":"Fabrizio","family":"Cantini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Niccoli Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Cassara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kaloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nannini Carlotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,7]]},"container-title":["Biologics: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:20:29Z","timestamp":1477866029000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/sustained-maintenance-of-clinical-remission-after-adalimumab-dose-redu-peer-reviewed-article-BTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/btt.s31145","relation":{},"ISSN":["1177-5475"],"issn-type":[{"value":"1177-5475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}